Fundraising Fox

Gregg Fine

Founder

Chief Executive Officer at Stork Therapeutics

San Francisco, California, United States

FoundedStork Therapeutics

About

Gregg Fine is the Founder and CEO of Stork Therapeutics and a physician-scientist trained in adult hematology/oncology, with subspecialty training in clinical informatics and a clinical focus on thrombosis/coagulation and immunotherapy. His drug development experience spans late-stage research through first-in-human studies, NDA/MAA filings, and commercial launch, including IND filings, accelerated approval, breakthrough therapy designation, companion diagnostic development, and cell and gene therapy programs such as lipid nanoparticle mRNA neoantigen cancer vaccines, gene-edited TCR T cells, and CAR T therapies for solid and liquid tumors. He has served on executive leadership teams from seed stage through initial public offering and has supported Series A ($200M) and Series C ($75M) financings, with therapeutic experience in genitourinary oncology, melanoma, synov

Chief Executive Officer at Stork Therapeutics

Experience

  1. Stork TherapeuticsFounder & CEOcurrent2023 — present
  2. CARGO TherapeuticsStrategic Advisor2023San Francisco Bay Area
  3. CARGO TherapeuticsChief Medical Officer2021 — 2023San Francisco Bay Area
  4. GSKVice President-Clinical Development, Cell and Gene Therapy-Oncology2020 — 2021
  5. PACT PharmaVice President, Head of Clinical Development2018 — 2019South San Francisco
  6. GenentechSenior Medical Director2016 — 2018
  7. GenentechMedical Director2013 — 2016
  8. GenentechAssistant Medical Director2010 — 2013
  9. GenentechAssociate Medical Director2009 — 2010
  10. Beth Israel Deaconess Medical CenterHematology/Oncology Fellow2006 — 2010
  11. OQO, Inc.Consultant2005 — 2006
  12. Baton SoftwareFounder2005
  13. Yale New Haven HospitalResident2002 — 2005

Frequently asked questions

Who is Gregg Fine?
Gregg Fine is the Founder and CEO of Stork Therapeutics and a physician-scientist trained in adult hematology/oncology, with subspecialty training in clinical informatics and a clinical focus on thrombosis/coagulation and immunotherapy. His drug development experience spans late-stage research through first-in-human studies, NDA/MAA filings, and commercial launch, including IND filings, accelerated approval, breakthrough therapy designation, companion diagnostic development, and cell and gene therapy programs such as lipid nanoparticle mRNA neoantigen cancer vaccines, gene-edited TCR T cells, and CAR T therapies for solid and liquid tumors. He has served on executive leadership teams from seed stage through initial public offering and has supported Series A ($200M) and Series C ($75M) financings, with therapeutic experience in genitourinary oncology, melanoma, synov
Where does Gregg Fine work?
Gregg Fine is Chief Executive Officer of Stork Therapeutics.
What companies did Gregg Fine found?
Gregg Fine founded Stork Therapeutics.
Where did Gregg Fine go to school?
Gregg Fine studied at The Robert Larner, M.D. College of Medicine at The University of Vermont (M.D., Medicine); Colgate University; Colgate University.

Are you in our directory? — or find your own page and tap it there to see your paths to every investor.

Founder mafias

Colgate University mafia20

Also came through, then founded or led a company.

Jake SeipBAFounded Aero +1Matthew GlickBachelor of Arts - BAFounded Gipper +1Philip OdelfeltBachelor's degreeFounded Flowlie +1Jim CacioppoBSFounded Jushi +1Daniel BarabanderBachelor of Arts (B.A.) salutatorian of class / summa cum laudeFounded HaywheelElise BatesBachelor's degreeFounded Attane Health

+ 13 more

The Robert Larner, M.D. College of Medicine at The University of Vermont mafia5

Also came through, then founded or led a company.

Jeff LawsonDoctor of Medicine - MDFounded Humacyte +1Amanda Wilson, MD, DFASAMMDFounded Northstarcare +1Erik SchaeferPh.D.Founded AssayQuant TechnologiesJohn DidsburyPh.D.Founded T3D Therapeutics

Same school

Also attended The Robert Larner, M.D. College of Medicine at The University of Vermont4

Jeff LawsonPhysician-Scientist, Inventor, Entrepreneur, Innovator, and Investor at Swift Street CapitalAmanda Wilson, MD, DFASAMFounder at NorthstarcareErik SchaeferExecutive Officer at AssayQuant TechnologiesJohn DidsburyExecutive Officer, Director, Promoter at T3D Therapeutics

Also attended Colgate University139

David FialkowVenture capitalist and Academy Award-winning documentary filmmaker who co-founded General CatalystJack PierrepontInvestor at DN CapitalKelsey BeausoleilBusiness Development Network at Redpoint VenturesDevon McDonaldInvestor at OpenView Venture PartnersStephanie ManningCOO & Head of Platform at Lerer HippeauLaurabeth HarveyInvestor at EQT Ventures

+ 133 more

Shared employers

Also worked at Stork Therapeutics1

Brendan KennedyExecutive Officer, Director at Tilray

Also worked at GSK170

Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Victoria TaylorInvestor at MedicxiErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesJane SuhPrincipal on the AlleyCorp Healthcare teamCarol SuhPartner at ARCH Venture Partners

+ 164 more

Also worked at PACT Pharma2

Nina KjellsonInvestor at Canaan PartnersVijay PanduranganAngel at Olima Ventures

Also worked at Beth Israel Deaconess Medical Center44

Graham GardnerExecutive Partner at Flare Capital PartnersSun AltbachSenior Scientific Advisor at BOLD LongevityAndy BeckCEO, PathAI & Founding Pillar at Pillar VCDiane HessanSpecial Advisor at Data Point CapitalRichard StumacherClinical Advisor at Seae VenturesDanielle StrachmanInvestor at NZVC

+ 38 more